Effects of Transcutaneous Magnetic Spinal Cord Stimulation for Neurogenic Bladder in Patients with Spinal Cord Injury

Effects of Transcutaneous Magnetic Spinal Cord Stimulation for Neurogenic Bladder in Patients with Spinal Cord Injury: Single-center, Parallel design, Single-blind, Randomized control, and Prospective exploratory clinical trials

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0006741

Enrollment

Registered

2021-11-11

Start date

2021-11-03

Completion date

Unknown

Last updated

2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : -Target: No. 2-4 of the sacrum (Apply the figure 8 coil between No. 11 thoracic and No. 4 lumbar vertebrae so that stimulation can be applied to the level of 1-2 lumbar vertebrae acco

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Adult male or female between the ages of 19 and 90 2) Those diagnosed with traumatic/non-traumatic spinal cord injury with pleural effusion number 9 or higher 3) Those who have completed acute treatment after spinal cord injury 4) Those with neurogenic bladder findings as a result of urodynamic examination within 1 month 5) A person who has enough cognitive ability to understand and follow the instructions of the researcher 6) Those who voluntarily agree to participate in this clinical trial and sign the consent form 7) Currently, a patient who is inpatient treatment at the Department of Rehabilitation Medicine, or a patient who agrees to a total of 10 outpatient visits in 2 weeks

Exclusion criteria

Exclusion criteria: 1) If you have a history of urinary system disease 2) If it is accompanied by an existing serious neurogenic disease 3) If the life expectancy is less than 1 year or the vital signs are unstable due to other medical diseases (hepatobiliary tract, kidney, heart, lung-related) 4) Cases included in the exclusion criteria for repetitive magnetic stimulation [Pregnant women, cases of metal fixation of 10 or less thoracic vertebrae, cases of insertion of metal in the abdomen and pelvis, cases of implantation of an artificial pacemaker, etc.] 5) In the case where it is judged by the principal investigator that participation in this study is not appropriate

Design outcomes

Primary

Measure	Time frame
Urodynamic study	—

Secondary

Measure	Time frame
Bulbocavernosus Reflex Latency test/Pudendal Somatosensory Evoked Potential;Neurogenic bladder Symptom Score;Spinal Cord Injury - Quality of Life	—

Countries

Korea, Republic of

Contacts

Public ContactJihong Min

Pusan National University Yangsan Hospital

papered@hanmail.net+82-55-360-4000

Outcome results